Xcout Intel
Zumutor Biologics
Zumutor Biologics is an immuno-oncology company incorporated in the USA, with its primary office in Cambridge, Massachusetts. The company is a leading firm in the space of targeted NK cell therapeutics and utilizes proprietary naïve human phage/yeast display technology.
Subscribe to see Zumutor Biologics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Zumutor Biologics at a glance
Zumutor Biologics is a biologics company headquartered in United States. It has raised at least $13.5M across the 2 funding rounds on record. Its most recent funding round, Series B, raised $7.3M in June 2026. Xcout tracks 2 named people at Zumutor Biologics, including Maloy Ghosh (chief scientific officer).
Zumutor Biologics leadership
- Maloy Ghoshchief scientific officer
- Kavitha Iyer Rodriguesfounder
Zumutor Biologics funding rounds
At least $13.5M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $7.3M | — | |
| — | $6.2M | 5 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Recent Zumutor Biologics news
Investors
Zumutor Biologics competitors
A few of Zumutor Biologics's closest competitors — see the full list of competitors and alternatives →
Aviceda Therapeutics is a clinical-stage biotechnology company headquartered in Cambridge, Massachusetts, focused on glyco-immune checkpoint therapeutics. The company develops novel, immune-mediated therapies designed to treat inflammatory and blinding diseases. Their proprietary technology platform leverages glycobiology to modulate the immune system for patient benefit.
OncoMyx Therapeutics, Inc. is a biotechnology company headquartered in Phoenix, Arizona, that develops innovative oncolytic immunotherapies to target and destroy tumors.
Diagonal Therapeutics is a biotechnology company headquartered in Watertown, Massachusetts, pioneering disease-modifying clustering antibody therapeutics to target the root causes of devastating diseases.
Lifordi Immunotherapeutics, Inc. is a clinical-stage biotechnology company based in Burlington, Massachusetts, focused on developing antibody-drug conjugates (ADCs).
Caldera Therapeutics, Inc. is a Cambridge, Massachusetts-based clinical-stage biotechnology company focused on treatments such as a bispecific inflammatory bowel disease (IBD) asset.
Headquartered in South San Francisco, California, Chimera Bioengineering is a privately held biotechnology company focused on developing advanced cellular engineering technologies for cancer therapies.
Get Zumutor Biologics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Zumutor Biologics in Xcout Intel
- 2 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- 1 corporate event with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access